Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
ibandronsyre 50 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ibandronic acid (substance) |
Inferred relationship |
Some |
|
ibandronsyre 1 mg/ml koncentrat til intravenøs infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ibandronic acid (substance) |
Inferred relationship |
Some |
|
Product containing ibandronic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ibandronic acid (substance) |
Inferred relationship |
Some |
1 |
Ibandronic acid 1mg/mL injection solution 3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ibandronic acid (substance) |
Inferred relationship |
Some |
|
Ibandronic acid 1mg/mL injection solution 6mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ibandronic acid (substance) |
Inferred relationship |
Some |
|
Ibandronic acid 1mg/mL injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ibandronic acid (substance) |
Inferred relationship |
Some |
|
Ibandronic acid therapy |
Direct substance |
True |
Ibandronic acid (substance) |
Inferred relationship |
Some |
2 |
ibandronsyre 50 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ibandronic acid (substance) |
Inferred relationship |
Some |
1 |
ibandronsyre 50 mg tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ibandronic acid (substance) |
Inferred relationship |
Some |
1 |
ibandronsyre 50 mg tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Ibandronic acid (substance) |
Inferred relationship |
Some |
1 |
Ibandronate sodium (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Ibandronic acid (substance) |
Inferred relationship |
Some |
|
Ibandronic acid-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ibandronic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing ibandronic acid in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ibandronic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing only ibandronic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ibandronic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing only ibandronic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ibandronic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing only ibandronic acid in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ibandronic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ibandronic acid (as ibandronate sodium monohydrate) 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ibandronic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ibandronic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ibandronic acid (as ibandronate sodium) 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ibandronic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ibandronic acid (as ibandronate sodium) 150 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ibandronic acid (substance) |
Inferred relationship |
Some |
1 |